Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9034300 | GISKIT | Composition and method for medical imaging of body cavities |
Oct, 2030
(7 years from now) | |
US9259494 | GISKIT | Composition and method for medical imaging of body cavities |
May, 2035
(12 years from now) | |
US9849199 | GISKIT | Composition and method for medical imaging of body cavities |
Feb, 2036
(12 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity (NCE) | Nov 7, 2024 |
Drugs and Companies using AIR POLYMER-TYPE A ingredient
NCE-1 date: 2023-11-08
Market Authorisation Date: 07 November, 2019
Treatment: Use in sonohysterosalpinography to assess fallopian tube patency
Dosage: FOAM;INTRAUTERINE
4
United States
2
Netherlands
1
Poland
1
Denmark
1
Spain
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic